FDA PMA for CryoLife’s New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System

CryoLife, Inc.has announced that it has received U.S. FDA premarket approval for its new Sologrip® minimally invasive laser fiber-optic delivery system, a single-use, disposable handset designed for use with the Company’s Cardiogenesis transmyocardial revascularization system.

CryoLife Receives FDA Premarket Approval (PMA) for New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System (via PR Newswire)

ATLANTA, July 10, 2013 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration (FDA) premarket…

published: July 10, 2013 in: Approval/Clearance, Cardio

Most read

Latest

^